Comparison of Eight Technologies to Determine Genotype at the UGT1A1 (TA)


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
30 Jan 2020
Historique:
received: 16 12 2019
revised: 21 01 2020
accepted: 28 01 2020
entrez: 6 2 2020
pubmed: 6 2 2020
medline: 11 11 2020
Statut: epublish

Résumé

To ensure accuracy of

Identifiants

pubmed: 32019188
pii: ijms21030896
doi: 10.3390/ijms21030896
pmc: PMC7037496
pii:
doi:

Substances chimiques

Irinotecan 7673326042
UGT1A1 enzyme EC 2.4.1.-
Glucuronosyltransferase EC 2.4.1.17

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIH HHS
ID : ZIA BC 010627
Pays : United States

Références

Pharmacogenetics. 2002 Dec;12(9):725-33
pubmed: 12464801
J Mol Diagn. 2008 Nov;10(6):549-52
pubmed: 18832463
Clin Biochem. 2007 Jun;40(9-10):710-7
pubmed: 17459361
Pediatr Res. 2016 Mar;79(3):378-86
pubmed: 26595536
Clin Pharmacol Ther. 2016 Apr;99(4):363-9
pubmed: 26417955
Hum Genomics. 2010 Apr;4(4):238-49
pubmed: 20511137
Am J Hum Genet. 2015 Jan 8;96(1):37-53
pubmed: 25529636
Pharmacogenetics. 1999 Jun;9(3):341-9
pubmed: 10471066
J Clin Pharmacol. 2017 Oct;57 Suppl 10:S67-S77
pubmed: 28921647
Pharmacotherapy. 2010 May;30(5):529-38
pubmed: 20412002
Pharmacotherapy. 2008 Jun;28(6):755-68
pubmed: 18503403
J Cancer. 2017 Feb 25;8(4):691-703
pubmed: 28367249
Cancer Res. 2000 Feb 15;60(4):950-6
pubmed: 10706110
Pharmacogenomics. 2015;16(5):441-8
pubmed: 25916516
J Clin Lab Anal. 2016 Jan;30(1):84-9
pubmed: 25545261
Pharmacogenomics J. 2010 Jun;10(3):191-9
pubmed: 20038957
Therapie. 2017 Apr;72(2):205-215
pubmed: 28262261
PLoS One. 2019 Feb 28;14(2):e0212097
pubmed: 30817750

Auteurs

Tristan M Sissung (TM)

Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Roberto H Barbier (RH)

Molecular Pharmacology Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Douglas K Price (DK)

Molecular Pharmacology Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Teri M Plona (TM)

CLIA Molecular Diagnostics Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD 21702, USA.

Kristen M Pike (KM)

CLIA Molecular Diagnostics Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD 21702, USA.

Stephanie D Mellott (SD)

CLIA Molecular Diagnostics Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD 21702, USA.

Ryan N Baugher (RN)

CLIA Molecular Diagnostics Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD 21702, USA.

Gordon R Whiteley (GR)

CLIA Molecular Diagnostics Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD 21702, USA.

Daniel R Soppet (DR)

Genomics Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD 21702, USA.

David Venzon (D)

Biostatistics and Data Management, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA.

Arlene Berman (A)

Office of Research Nursing in the Office of the Clinical Director, National Cancer Institutes, National Institutes of Health, Bethesda, MD 20892, USA.

Arun Rajan (A)

Thoracic and Gastrointestinal Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Giuseppe Giaccone (G)

Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA.

Paul Meltzer (P)

Genetics Branch, National Cancer Institute, Bethesda, MD 20814, USA.

William D Figg (WD)

Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Molecular Pharmacology Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH